BioMed Realty Trust, Inc. (BMR) Reports In-Line Q2 FFO, Revenues Top Slightly
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $106.8 million versus the consensus estimate of $105.56 million.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.